Search results :

Iloprost

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: B01AC11

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Cough Cough increased 39% 13% - 26% x x x x
Cough x
Headache Headache 30% 10% - 20% x x x x x
Flushing Flushing 27% 9% - 18% x x x x
Vasodilation procedure Vasodilation 27% 9% - 18% x x x x
Influenza Influenza 14% 4% - 10% x x x x
Nausea Nausea 13% 5% - 8% x x x x x
Trismus Trismus 12% 3% - 9% x x x x x
Hypotension Hypotension 11% 5% - 6% x x x x x
Dizziness Syncope 8% 3% - 5% x x x x x
Dizziness postmarketing x x x x x
Shock Syncope 8% 3% - 5% x x x x x
Syncope Syncope 8% 3% - 5% x x x x x
Loss of consciousness Syncope 8% 3% - 5% x x x x x
Insomnia Insomnia 8% 2% - 6% x x x x
Back pain Back pain 7% 3% - 4% x x x x
Palpitations Palpitations 7% 3% - 4% x x x x x
Vomiting Vomiting 7% 2% - 5% x x x x x
Laboratory test abnormal Laboratory test abnormal 7% 3% - 4% x x x
Muscle spasms Cramp muscle 6% 3% x x x x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased 6% 3% x x x x
Blood alkaline phosphatase increased Phosphatase alkaline increased 6% 1% - 5% x x x x
Haemoptysis Haemoptysis postmarketing, 5% 2% - 3% x x x x x
Glossodynia Glossodynia 4% 0% - 4% x x x x
Pneumonia Pneumonia 4% 1% - 3% x x x x
Bronchospasm Bronchospasm postmarketing x x x
Diarrhoea Diarrhoea postmarketing x x x
Dysgeusia Dysgeusia postmarketing x x
Epistaxis Epistaxis postmarketing x x x x
Dermatitis Rash postmarketing x x
Rash Rash postmarketing x x
Gingival bleeding Gingival bleeding postmarketing x x
Haemorrhage Haemorrhage postmarketing x x
Haemoglobin Haemorrhage postmarketing x x
Hypersensitivity Hypersensitivity postmarketing x x
Nasal congestion Nasal congestion postmarketing x
Thrombocytopenia Thrombocytopenia postmarketing x x
Wheezing Wheezing postmarketing x x x
Drug interaction Drug interaction postmarketing x
Glossitis Tongue irritation postmarketing x x
Chest pain Chest pain x x x x x
Chest discomfort x
Connective tissue disorder Connective tissue disorder x
Dyspnoea Dyspnoea x x x x x
Gastrointestinal disorder Gastrointestinal disorder x
Cardiac disorder Cardiac disorder x
Cardiac failure congestive Cardiac failure congestive x x x x
Immune system disorder Immune system disorder x
Mediastinal disorder Mediastinal disorder x
Nervous system disorder Nervous system disorder x
Pain Pain x
Renal failure Renal failure x x x x
Tachycardia Tachycardia x
Supraventricular tachycardia Supraventricular tachycardia x x x x
Angiopathy Angiopathy x
Oedema peripheral Oedema peripheral x x x x x
Haemorrhage intracranial Haemorrhage intracranial x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Discomfort Discomfort x x x x
Chest discomfort Chest discomfort x
Pain in jaw Pain in jaw x
Throat irritation Throat irritation x
Laryngeal pain Pharyngolaryngeal pain x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ILOPROST / VENTAVIS

Side effects:28
Source:FDA

ILOPROST / VENTAVIS

Side effects:30
Source:FDA

ILOPROST / VENTAVIS

Side effects:33
Source:FDA

iloprost

Side effects:39
Source:FDA Structured Product Label

iloprost / iloprost

Side effects:39
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label